🔎 Trials Near Me

Home › Breast Cancer › Missouri › Columbia

Breast Cancer clinical trials in Columbia, MO

6 studies for Breast Cancer are looking for participants at sites in and around Columbia (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

RecruitingPhase 2
  • Missouri Cancer Associates, Columbia
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06369285

Cognitive Rehabilitation Following Breast Cancer Treatment

Recruiting
  • University of Missouri, Columbia
Ages 20 to 75 · Women · Updated Sep 22, 2026 · NCT06545045

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

RecruitingPhase 3
  • MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
Ages 50 to 70 · All sexes · Updated Apr 23, 2026 · NCT04852887

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

RecruitingPhase 3
  • Capital Region Southwest Campus, Jefferson City · 27 mi away
Ages 18 and older · All sexes · Updated Oct 8, 2025 · NCT03418961

About Breast Cancer

Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.

More about Breast Cancer on MedlinePlus

Breast Cancer trials in other cities

Other studies in Columbia

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.